_version_ 1783699557613305856
author Toapanta, Nestor
Castañeda, Zaira
Zúñiga, José
León-Román, Juan
Ramos, Natalia
Azancot, María
Soler, María José
author_facet Toapanta, Nestor
Castañeda, Zaira
Zúñiga, José
León-Román, Juan
Ramos, Natalia
Azancot, María
Soler, María José
author_sort Toapanta, Nestor
collection PubMed
description
format Online
Article
Text
id pubmed-8156899
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología.
record_format MEDLINE/PubMed
spelling pubmed-81568992021-05-28 Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis Toapanta, Nestor Castañeda, Zaira Zúñiga, José León-Román, Juan Ramos, Natalia Azancot, María Soler, María José Nefrologia Carta al Director Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología. 2022 2021-05-27 /pmc/articles/PMC8156899/ /pubmed/34075266 http://dx.doi.org/10.1016/j.nefro.2021.04.004 Text en © 2021 Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Carta al Director
Toapanta, Nestor
Castañeda, Zaira
Zúñiga, José
León-Román, Juan
Ramos, Natalia
Azancot, María
Soler, María José
Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis
title Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis
title_full Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis
title_fullStr Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis
title_full_unstemmed Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis
title_short Seropositividad frente al SARS-CoV-2 en pacientes en hemodiálisis
title_sort seropositividad frente al sars-cov-2 en pacientes en hemodiálisis
topic Carta al Director
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156899/
https://www.ncbi.nlm.nih.gov/pubmed/34075266
http://dx.doi.org/10.1016/j.nefro.2021.04.004
work_keys_str_mv AT toapantanestor seropositividadfrentealsarscov2enpacientesenhemodialisis
AT castanedazaira seropositividadfrentealsarscov2enpacientesenhemodialisis
AT zunigajose seropositividadfrentealsarscov2enpacientesenhemodialisis
AT leonromanjuan seropositividadfrentealsarscov2enpacientesenhemodialisis
AT ramosnatalia seropositividadfrentealsarscov2enpacientesenhemodialisis
AT azancotmaria seropositividadfrentealsarscov2enpacientesenhemodialisis
AT solermariajose seropositividadfrentealsarscov2enpacientesenhemodialisis